Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Coherus BioSciences stock (CHRS)

Buy Coherus BioSciences stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Coherus BioSciences is a biotechnology business based in the US. Coherus BioSciences shares (CHRS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.04 – a decrease of 0.95% over the previous week. Coherus BioSciences employs 246 staff and has a trailing 12-month revenue of around $308.1 million.

Our top picks for where to buy Coherus BioSciences stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

Our pick for investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Coherus BioSciences stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CHRS. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Coherus BioSciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
eToro
Finder Score: 4 / 5: ★★★★★
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.9%
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.
Robinhood
Finder Score: 4.4 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Coherus BioSciences stock price (NASDAQ: CHRS)

Use our graph to track the performance of CHRS stocks over time.

Coherus BioSciences shares at a glance

Information last updated 2024-10-01.
Latest market close$1.04
52-week range$0.97 - $3.98
50-day moving average $1.32
200-day moving average $1.97
Wall St. target price$9.50
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.38

Is it a good time to buy Coherus BioSciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Coherus BioSciences price performance over time

Historical closes compared with the close of $1.04 from 2024-10-04

1 week (2024-09-27) -0.95%
1 month (2024-09-06) -16.13%
3 months (2024-07-05) -21.80%
6 months (2024-04-05) -57.20%
1 year (2023-10-06) -72.27%
2 years (2022-10-06) -89.31%
3 years (2021-10-06) 16.59
5 years (2019-10-04) 20.99

Coherus BioSciences financials

Revenue TTM $308.1 million
Gross profit TTM $-58,399,000
Return on assets TTM -16.05%
Return on equity TTM -1657.06%
Profit margin -9.52%
Book value $-0.73
Market Capitalization $119.8 million

TTM: trailing 12 months

Coherus BioSciences share dividends

We're not expecting Coherus BioSciences to pay a dividend over the next 12 months.

Coherus BioSciences share price volatility

Over the last 12 months, Coherus BioSciences's shares have ranged in value from as little as $0.9735 up to $3.98. A popular way to gauge a stock's volatility is its "beta".

CHRS.US volatility(beta: 0.67)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Coherus BioSciences's is 0.665. This would suggest that Coherus BioSciences's shares are less volatile than average (for this exchange).

Coherus BioSciences overview

Coherus BioSciences, Inc. , a biopharmaceutical company, focuses on the research, development, and commercialization of cancer treatments primarily in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel PD-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype G1 (IgG1) monoclonal antibody targeting interleukin 27. It is also developing CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody selectively targeting CCR8, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, an antibody targeting human ILT4 designed to improve anti-PD-1 clinical benefit by transforming an unfavorable TME to a more favorable TME. In addition, the company's licensed immuno-oncology programs include NZV930, an antibody designed to inhibit cluster of differentiation 73; and GSK4381562, an antibody targeting CD112R for the treatment of solid tumors. Further, it offers YUSIMRY, a biosimilar to Humira for the treatment of patients with inflammatory diseases characterized by increased production of tumor necrosis factor (TNF) in the body, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, and ulcerative colitis. It collaboration agreement with Junshi Biosciences for the co-development and commercialization of toripalimab; agreement with Surface and Adimab LLC; license agreements with Bioeq AG and Genentech, Inc.

Frequently asked questions

null
What percentage of Coherus BioSciences is owned by insiders or institutions?
Currently 1.386% of Coherus BioSciences shares are held by insiders and 74.708% by institutions.
How many people work for Coherus BioSciences?
Latest data suggests 246 work at Coherus BioSciences.
When does the fiscal year end for Coherus BioSciences?
Coherus BioSciences's fiscal year ends in December.
Where is Coherus BioSciences based?
Coherus BioSciences's address is: 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065
What is Coherus BioSciences's ISIN number?
Coherus BioSciences's international securities identification number is: US19249H1032
What is Coherus BioSciences's CUSIP number?
Coherus BioSciences's Committee on Uniform Securities Identification Procedures number is: 19249H103

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site